2025-07-01 00:40Investment Rating - The report maintains a "Buy" rating for both JD Health and Meituan, indicating a positive outlook for their stock performance in the healthcare sector [5][22]. Core Insights - The pharmaceutical retail O2O market in China is characterized by strong competition, with Meituan being the largest player due to its delivery capabilities and early market entry in 2013. JD Health is emerging as a significant competitor with advantages in supply chain and asset-heavy business model [2][4]. - Meituan's healthcare product GMV is estimated to reach approximately Rmb45 billion in 2023, with a target growth rate of at least 30% annually. The majority of its healthcare-related GMV comes from O2O sales [2][3]. - JD Health's asset-heavy model may provide a competitive edge in the healthcare industry, as many services require offline provision and have higher logistics demands. JD Health's scale gives it stronger bargaining power with suppliers [4][5]. Summary by Sections Meituan's Position - Meituan has captured a significant share of the pharmacy market, with around 250,000 pharmacies operating on its platform. The company aims to expand its healthcare segment despite challenges in driving growth due to market saturation [2][3]. - The expert suggests potential strategies for Meituan to enhance growth, including integration with the medical beauty segment and lobbying for reimbursement of O2O drug orders in more cities [3]. JD Health's Competitive Edge - JD Health operates its own offline pharmacies, which provides it with a supply chain advantage over Meituan. This model may be more suitable for the healthcare sector, where offline services are crucial [4]. - The report highlights that JD Health could outperform revenue growth expectations due to strong drug sales and gross profit margin expansion [5]. Market Outlook - The internet healthcare space is viewed positively due to its high growth visibility and potential catalysts such as AI and consumption recovery. Both JD Health and Meituan are expected to benefit from these trends [5].